Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809458 · ClinicalTrials.gov registry record · Phase 3
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer
A Phase 3 study, sponsored by New Mexico Cancer Research Alliance.
- Terminated
- Registry status
- Phase 3
- Development phase
- 15
- Enrollment target
NCT00809458 is a Phase 3 study that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 15 participants.
The verdict
NCT00809458, a Phase 3 study, was terminated before completion, sponsored by New Mexico Cancer Research Alliance.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if vitamin E can help treat prostate cancer. Vitamin E acts primarily as an anti-oxidant. By decreasing the oxidation in the cancer cell, the tumor cells may die. Vitamin E is a commonly used vitamin that has not been approved by the Food and Drug Administration for use in this type of cancer or for any known cancer. This study will test the hypothesis that vitamin E, in the setting of an oxidative stress such as smoking, can reduce prostate cancer related biomarkers in patients with localized prostate cancer in the neoadjuvant setting.
Interventions
- DRUG Vitamin E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00809458
The ClinicalTrials.gov registry entry for NCT00809458 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin E is the first listed.
NCT00809458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00809458 about?
NCT00809458 is a clinical study titled "Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer". The purpose of this study is to find out if vitamin E can help treat prostate cancer. Vitamin E acts primarily as an anti-oxidant. By decreasing the oxidation in the cancer cell, the tumor cells may die. Vitamin E is a commonly used vitamin that has not been approved by the Food and Drug Administrat...
What is the current status of trial NCT00809458?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2008-09. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00809458?
The interventions under investigation include: Vitamin E (DRUG).
Who is sponsoring clinical trial NCT00809458?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.